Long-term safety and efficacy data of high-dose sequential chemotherapy in high-risk early breast cancer patients treated in Italian institutions outside of clinical trials

被引：0
|
作者：
Sabbatini, R
Da Prada, GA
Frassineti, L
Siena, S
Maur, M
Zambelli, A
Giovannini, N
Pedrazzoli, P
Fregoni, V
Flamini, E
Conte, PF
机构：
[1] Policlin Hosp, Modena, Italy
[2] Maugeri Fdn, Pavia, Italy
[3] Osped Morgagni Pierantoni, Forli, Italy
[4] Ca Granda Niguarda, Milan, Italy
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S254 / S255
页数：2
相关论文
共 50 条
  • [1] High-dose sequential chemotherapy in patients with high-risk breast cancer
    Sabbatini, R
    Frassineti, L
    Depenni, R
    BONE MARROW TRANSPLANTATION, 2001, 27 : S119 - S119
  • [2] Long-term toxicity of high-dose sequential chemotherapy with autologous hematopoietic stem cells support in very high-risk early breast cancer patients (pts)
    Bernardi, A.
    Zamagni, C.
    Quercia, S.
    Massari, F.
    Cacciari, N.
    Martoni, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    Somlo, G
    Simpson, JF
    Frankel, P
    Chow, W
    Leong, L
    Margolin, K
    Morgan, R
    Raschko, J
    Shibata, S
    Forman, S
    Kogut, N
    McNamara, M
    Molina, A
    Somlo, E
    Doroshow, JH
    BRITISH JOURNAL OF CANCER, 2002, 87 (03) : 281 - 288
  • [4] Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer
    G Somlo
    J F Simpson
    P Frankel
    W Chow
    L Leong
    K Margolin
    R Morgan
    J Raschko
    S Shibata
    S Forman
    N Kogut
    M McNamara
    A Molina
    E Somlo
    J H Doroshow
    British Journal of Cancer, 2002, 87 : 281 - 288
  • [5] High-dose chemotherapy in high-risk breast cancer
    de Boer R.
    Breast Cancer Research, 2 (1)
  • [6] High-dose chemotherapy in high-risk breast cancer
    Price, LA
    LANCET, 1998, 352 (9139): : 1551 - 1552
  • [7] End of high-dose chemotherapy for high-risk breast cancer patients?
    Tuma, Rabiya S.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (09) : 618 - U3
  • [8] Patient selection in high-dose chemotherapy trials: Relevance in high-risk breast cancer
    GarciaCarbonero, R
    Hidalgo, M
    PazAres, L
    Calzas, J
    Gomez, H
    Guerra, JA
    Hitt, R
    Hornedo, J
    Colomer, R
    CortesFunes, H
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) : 3178 - 3184
  • [9] Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy
    Nieto, Y
    Nawaz, S
    Shpall, EJ
    Bearman, SI
    Murphy, J
    Jones, RB
    CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2609 - 2617
  • [10] High-dose chemotherapy in high-risk breast cancer - Reply
    Pusztai, L
    Hortobagyi, GN
    LANCET, 1998, 352 (9139): : 1552 - 1552
12345